The human factor in health
Kal'chenko, E.I.
Vrachebnoe Delo 1990(9): 110-112
1990
ISSN/ISBN: 0049-6804 PMID: 2284747 Document Number: 361229
Document emailed within 1 workday
Related Documents
Bialas, T.; Kolitz, J.; Levi, E.; Polivka, A.; Oez, S.; Miller, G.; Welte, K. 1988: Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin Cancer Research 48(4): 891-898Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Hatake, K.; Motoyoshi, K.; Hanamura, T.; Mukaida, N.; Kasahara, T.; Miura, Y.; Saito, M. 1987: Differentiation-inducing factor for a human leukemic cell line produced by colony-stimulating factor producing human lung cancer tissue Experimental Hematology 15(9): 915-921
Palmantier, R.; Surette, M.E.; Sanchez, A.; Braquet, P.; Borgeat, P. 1994: Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha Laboratory Investigation; A Journal of Technical Methods and Pathology 70(5): 696-704
Svanvik, J. 2001: For safer health care: Analyse the "human factor"! Lakartidningen 98(36): 3770-3771
Brown, E.J.; Joiner, K.A.; Gaither, T.A.; Hammer, C.H.; Frank, M.M. 1983: The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system Journal of Immunology 131(1): 409-415
Váradi, K.; Rosing, J.; Tans, G.; Schwarz, H.P. 1995: Influence of factor V and factor Va on APC-induced cleavage of human factor VIIi Thrombosis and Haemostasis 73(4): 730-731
Xavier, R.M.; Nakamura, M.; Tsunematsu, T. 1994: Isolation and characterization of a human nonspecific suppressor factor from ascitic fluid of systemic lupus erythematosus. Evidence for a human counterpart of the monoclonal nonspecific suppressor factor and relationship to the T cell receptor alpha-chain Journal of Immunology 152(5): 2624-2632
Lane, J.L.; Ekert, H.; Vafiadis, A. 1979: Affinity chromatography of human factor VIII using human and rabbit antibodies to Factor VIII Thrombosis and Haemostasis 42(4): 1306-1315
Liu, D.Y.; Rosen, S. 1994: Activation of bovine factor IX by the reaction product of bovine factor VIi and human tissue factor Chinese Medical Journal 107(3): 181-185
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Shibayama, Y.; Brunnee, T.; Kaplan, A.P.; Reddigari, S. 1994: Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions Brazilian Journal of Medical and Biological Research 27(8): 1817-1828
Levine, P.H. 1988: Human factor VIII:C purified using monoclonal antibody to von Willebrand factor Seminars in Hematology 25(2 Suppl 1: 1-2
Horstmann, R.D.; Müller-Eberhard, H.J. 1985: Isolation of rabbit C3, Factor B, and Factor H and comparison of their properties with those of the human analog Journal of Immunology 134(2): 1094-1100
Farr, R.S.; Wardlow, M.L.; Cox, C.P.; Meng, K.E.; Greene, D.E. 1983: Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor Federation Proceedings 42(14): 3120-3122
Hu, M.; Pollock, R.E.; Nicolson, G.L. 1997: Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue sarcoma cells: identification as an NH2-terminal fragment of human fibronectin Cancer Research 57(16): 3577-3584
Valone, F.H.; Epstein, L.B. 1988: Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma Journal of Immunology 141(11): 3945-3950
Espevik, T.; Figari, I.S.; Ranges, G.E.; Palladino, M.A. 1988: Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1 Journal of Immunology 140(7): 2312-2316
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59